A safety and feasibility study of cell therapy in dilated cardiomyopathy

Autor:	Ricardo Sa, Bernardo R Tura, Helena Furtado Martino, F.B. Muccillo, Fernando César Castro Souza, S.N.S. Arvelo, Pedro Oliveira, Aylla Beatriz Melo de Oliveira, A.C. Campos de Carvalho, Thais Guimarães, E. Assunção e Silva, Miriam Gaze, Rita Villela, Luiz Henrique Weitzel, Patricia C. Costa
Rok vydání:	2010
Předmět:	Adult Cardiomyopathy Dilated Male medicine.medical_specialty Physiology Immunology Biophysics Biochemistry Severity of Illness Index Young Adult Quality of life Internal medicine Idiopathic dilated cardiomyopathy medicine Autologous transplantation Humans General Pharmacology Toxicology and Pharmaceutics Aged Bone Marrow Transplantation Ejection fraction medicine.diagnostic_test business.industry General Neuroscience Magnetic resonance imaging Dilated cardiomyopathy Cell Biology General Medicine Middle Aged medicine.disease Surgery Transplantation Clinical trial Treatment Outcome Cardiology Feasibility Studies Female business Follow-Up Studies
Zdroj:	Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 43(10)
ISSN:	1414-431X
Popis:	The aim of this study was to determine if bone marrow mononuclear cell (BMMC) transplantation is safe for moderate to severe idiopathic dilated cardiomyopathy (IDC). Clinical trials have shown that this procedure is safe and effective for ischemic patients, but little information is available regarding non-ischemic patients. Twenty-four patients with IDC, optimized therapy, age 46 ± 11.6 years, 17 males, NYHA classes II-IV, and left ventricular ejection fraction
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8abb5be14e9b4676066536a5238760d9 https://pubmed.ncbi.nlm.nih.gov/20878013 Zobrazit plný text záznamu